RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
106.24B
VYCGX
Price
$25.93
Change
+$0.22 (+0.86%)
Updated
Jun 26 closing price
Net Assets
1.13B
Interact to see
Advertisement

RMEBX vs VYCGX

Header iconRMEBX vs VYCGX Comparison
Open Charts RMEBX vs VYCGXBanner chart's image
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets106.24B
Voya Corporate Leaders 100 R6
Price$25.93
Change+$0.22 (+0.86%)
VolumeN/A
Net Assets1.13B
RMEBX vs VYCGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RMEBX vs. VYCGX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMEBX is a Buy and VYCGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 106B vs. VYCGX (1.13B). VYCGX pays higher dividends than RMEBX: VYCGX (1.81) vs RMEBX (1.16). RMEBX was incepted earlier than VYCGX: RMEBX (11 years) vs VYCGX (11 years). RMEBX (1.07) is less costly to investors than VYCGX (0.54). RMEBX is a more actively managed with annual turnover of: 31.00 vs. VYCGX (24.00). RMEBX has a lower initial minimum investment than VYCGX: RMEBX (250) vs VYCGX (1000000). VYCGX annual gain was more profitable for investors over the last year : 10.75 vs. RMEBX (9.50). RMEBX return over 5 years is better than : 62.71 vs. VYCGX (47.16).
RMEBXVYCGXRMEBX / VYCGX
Total Expense Ratio1.070.48223%
Annual Report Gross Expense Ratio1.070.54198%
Fund Existence11 years11 years-
Gain YTD7.3156.991105%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets106B1.13B9,372%
Annual Yield % from dividends1.161.8164%
Returns for 1 year9.5010.7588%
Returns for 3 years25.8838.5467%
Returns for 5 years62.7147.16133%
Returns for 10 years74.5167.54110%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp